Haiquan Lu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Transcription Factor

Cancer Stem Cells

Optical Coherence Tomography

Top Venues

Science advances

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Guangyu Ji, Jia Liu, Zhiqun Zhao, Jie Lan, You Yang, Zheng Wang, Huijing Feng, Kai Ji, Xiaofeng Jiang, Huize Xia, Guangyao Wei, Yajing Zhang, Yuhong Zhang, Xinlong Du, Yawen Wang, Yuanyuan Yang, Zhaojian Liu, Kai Zhang, Qi Mei, Rong Sun, Haiquan Lu
Polyamine Anabolism Promotes Chemotherapy-Induced Breast Cancer Stem Cell Enrichment. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Yongkang Yang, Chelsey Chen, Qiaozhu Zuo, Haiquan Lu, Shaima Salman, Yajing Lv, Tina Yi-Ting Huang, Elizabeth E Wicks, Walter Jackson, Emmanuel Datan, Ru Wang, Yufeng Wang, Nguyet Le, Yayun Zhu, Wenxin Qin, Gregg L Semenza
NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification. Science advances 8 (49) (2022)
Yongkang Yang, Chelsey Chen, Qiaozhu Zuo, Haiquan Lu, Shaima Salman, Yajing Lv, Tina Yi-Ting Huang, Elizabeth E Wicks, Walter Jackson, Emmanuel Datan, Ru Wang, Yufeng Wang, Nguyet Le, Yayun Zhu, Wenxin Qin, Gregg L Semenza
NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification. Science advances 8 (49) (2022)
Yongkang Yang, Chelsey Chen, Qiaozhu Zuo, Haiquan Lu, Shaima Salman, Yajing Lv, Tina Yi-Ting Huang, Elizabeth E Wicks, Walter Jackson, Emmanuel Datan, Ru Wang, Yufeng Wang, Nguyet Le, Yayun Zhu, Wenxin Qin, Gregg L Semenza
NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification. Science advances 8 (49) (2022)
Yongkang Yang, Chelsey Chen, Qiaozhu Zuo, Haiquan Lu, Shaima Salman, Yajing Lv, Tina Yi-Ting Huang, Elizabeth E Wicks, Walter Jackson, Emmanuel Datan, Ru Wang, Yufeng Wang, Nguyet Le, Yayun Zhu, Wenxin Qin, Gregg L Semenza
NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification. Science advances 8 (49) (2022)
Yongkang Yang, Chelsey Chen, Qiaozhu Zuo, Haiquan Lu, Shaima Salman, Yajing Lv, Tina Yi-Ting Huang, Elizabeth E Wicks, Walter Jackson, Emmanuel Datan, Ru Wang, Yufeng Wang, Nguyet Le, Yayun Zhu, Wenxin Qin, Gregg L Semenza
NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification. Science advances 8 (49) (2022)
Yongkang Yang, Chelsey Chen, Qiaozhu Zuo, Haiquan Lu, Shaima Salman, Yajing Lv, Tina Yi-Ting Huang, Elizabeth E Wicks, Walter Jackson, Emmanuel Datan, Ru Wang, Yufeng Wang, Nguyet Le, Yayun Zhu, Wenxin Qin, Gregg L Semenza
NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification. Science advances 8 (49) (2022)
Yongkang Yang, Chelsey Chen, Qiaozhu Zuo, Haiquan Lu, Shaima Salman, Yajing Lv, Tina Yi-Ting Huang, Elizabeth E Wicks, Walter Jackson, Emmanuel Datan, Ru Wang, Yufeng Wang, Nguyet Le, Yayun Zhu, Wenxin Qin, Gregg L Semenza
NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification. Science advances 8 (49) (2022)